CLINICAL_TRIALS
trial_result
· 2013-10-11
Clinical Trial Update: Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain [Phase 3]
Summary
Phase 3 long-term safety and efficacy study of fentanyl sublingual spray for breakthrough cancer pain completed; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: INSYS Therapeutics Inc | Conditions: Cancer, Pain | Phase 3 | Status: COMPLETED | Results posted: 2013-10-11